Israel’s SpliSense (see here previously) uses mRNA to fix the root cause of cystic fibrosis – genetic mutations that create a non-functioning protein (CFTR). It not only treats patients with no current treatment but is also much cheaper than existing treatments.
https://www.israel21c.org/inhaled-drug-could-treat-rare-cystic-fibrosis-mutations/